IN-VITRO SUSCEPTIBILITY OF OXACILLIN, VANCOMYCIN AND TEICOPLANIN AGAINST CLINICAL STRAINS OF STAPHYLOCOCCI
International Journal of Biomedical and Advance Research · 2011
DOI: 10.7439/ijbar.v1i4.11 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Biomedical and Advance Research, 2011. Verfasst von Daniyan S. Y. und 3 weiteren Autor:innen.
Abstract (Originalsprache)
In athreogenic diet induced hyperlipedimia model, the rats receiving treatments with the aqueous and ethanolic extracts of the root of Bauhinia variegata shows significant reduction in Total cholesterol, Triglycerides, Very low density lipoprotein and elevated in High density lipoprotein cholesterol. The ethanolic extract of B. variegata was found to posses significant hypolipedemic activity. The results also suggest that B. variegata root extract at 200 and 400mg/kg b. wt. concentration is an excellent lipid lowering agent.
Zitieren
APA
Y., D. S., M., G., J., I. U., & E., O. L. (2011). IN-VITRO SUSCEPTIBILITY OF OXACILLIN, VANCOMYCIN AND TEICOPLANIN AGAINST CLINICAL STRAINS OF STAPHYLOCOCCI. International Journal of Biomedical and Advance Research. https://doi.org/10.7439/ijbar.v1i4.11
Vancouver
Y. DS, M. G, J. IU, E. OL. IN-VITRO SUSCEPTIBILITY OF OXACILLIN, VANCOMYCIN AND TEICOPLANIN AGAINST CLINICAL STRAINS OF STAPHYLOCOCCI. International Journal of Biomedical and Advance Research. 2011. doi:10.7439/ijbar.v1i4.11
BibTeX
@article{Y2011,
author = {Y., Daniyan S. and M., Galadima and J., Ijah U.J. and E., Odama L.},
title = {IN-VITRO SUSCEPTIBILITY OF OXACILLIN, VANCOMYCIN AND TEICOPLANIN AGAINST CLINICAL STRAINS OF STAPHYLOCOCCI},
journal = {International Journal of Biomedical and Advance Research},
year = {2011},
doi = {10.7439/ijbar.v1i4.11}
}
EUVIMED